Pair page — what's published on the two together
Sermorelin with Testosterone
Studied together only in 14 men on testosterone therapy who added sermorelin with GHRP-2 and GHRP-6, in 2017.
The receipt
1 study gave them to people together
Human pilots · 1 record review, 14 men (2017)
- Evidence on the combination
- Human pilots
What each does alone
- Muscle & strength · Daily shotSermorelinGH secretagogueThe first FDA-approved growth-hormone releaser, now compounded for adults. The approval was for kids, 1997.Controlled trialsCompounded RxChecked Oct 18
- Libido & hormones · Weekly shotTestosteroneHormonePrescribed for low testosterone; also the original anabolic steroid. Normal is 300–1,000 ng/dL.Approved drugFDA approvedChecked Oct 23
Mechanism overlap · reasoning, not evidence
- Sermorelin
- Peptide — GHRH Analog, Growth Hormone Secretagogue
- Testosterone
- Androgen — Primary Male Sex Hormone
Reasoning, not evidence: what each is described to do says nothing about what they do together.
What the studies found
Men on testosterone therapy (Sigalos et al., 2017)
- What was given — A retrospective review of 105 hypogonadal men on testosterone therapy who were prescribed GHRP-6, GHRP-2 and sermorelin together, 100 mcg of each injected under the skin three times a day (started 2012–2015). 14 men met the strict compliance criteria and were analysed.
- What it found — IGF-1 rose from 159.5 to 239.0 ng/mL (p < .0001) over a mean 134 days of treatment. Men also taking an aromatase inhibitor or tamoxifen had smaller rises. In the full text, testosterone and free testosterone rose significantly from 90 days on; LH, FSH and estradiol did not change.
- Limits — No control group, and the three peptides were always given together, so no single peptide's effect can be separated. Anthropometric data were missing for most men.
No study has added sermorelin alone to testosterone therapy.
Legal Status
Sermorelin: Compounded Rx. Once an approved drug (Geref, 1990–2008); compounded legally today.
Testosterone: FDA approved. Prescribed by a doctor, made by a manufacturer.
References
- Sigalos JT, Pastuszak AW, Allison A, Ohlander SJ, Herati A, et al. Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels. Am J Mens Health. 2017;11(6):1752-1757. PMID: 28830317.
Checked 14 Oct 2026 | A literature lookup, not a recommendation to combine anything.